Multiple MyelomaPlasma CellsNeoplasms, Plasma CellPlasmacytomaImmunoproliferative DisordersSyndecan-1Myeloma ProteinsProto-Oncogene Proteins c-bcl-6Leukemia, Plasma CellImmunophenotypingBoronic AcidsLymphomaPyrazinesParaproteinemiasThalidomideLymphoma, AIDS-RelatedIn Situ Hybridization, FluorescenceFlow CytometryMelphalanAntigens, CDImmunohistochemistryMonoclonal Gammopathy of Undetermined SignificanceBone MarrowDexamethasoneTransplantation, AutologousBence Jones ProteinImmunoglobulin Light ChainsPlasmaCell Line, TumorParaproteinsAntineoplastic AgentsImmunoglobulin kappa-ChainsInterleukin-6Bone Marrow CellsB-LymphocytesImmunoglobulin lambda-ChainsSyndecansWaldenstrom MacroglobulinemiaOsteolysisBone DiseasesAntineoplastic Combined Chemotherapy ProtocolsTumor Cells, CulturedProteasome InhibitorsHematopoietic Stem Cell TransplantationApoptosisGranuloma, Plasma CellImmunoglobulinsChromosomes, Human, Pair 14Immunoglobulin AMice, SCIDAmyloidosisImmunoglobulin GPrognosisHypergammaglobulinemiaVincristineAntibodies, MonoclonalTreatment OutcomeTranslocation, GeneticPrednisoneDiphosphonatesBone Marrow ExaminationGene Expression Regulation, NeoplasticImmunoglobulin DAntineoplastic Agents, AlkylatingRemission InductionDoxorubicinDrug Resistance, NeoplasmCell SurvivalReceptors, Interleukin-6Stem Cell Transplantationbeta 2-MicroglobulinCell ProliferationMaintenance ChemotherapyTime FactorsMembrane GlycoproteinsStromal CellsDisease ProgressionProtease InhibitorsImmunoglobulin MRecurrenceNeoplasm ProteinsSurvival AnalysisCombined Modality TherapyAntigens, CD19Survival RateCyclophosphamideChromosomes, Human, Pair 13Signal TransductionAntigens, CD38Genes, ImmunoglobulinImmunoelectrophoresisDisease-Free SurvivalOsteoclasts